ANAB vs K · rev $91.3M vs P/E 23, $29.03B cap
AnaptysBio Inc (ANAB) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Kellanova (K) is a packaged foods company listed on US.
Latest reported ANAB revenue for 2024-12-31 was $91.3M. Net income was -$145.2M. Revenue was up 432.0% from 2023-12-31 to 2024-12-31. ANAB currently screens at market cap $1.62B.
K does not have a complete income-statement cache yet.
ANAB currently screens at market cap $1.62B. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the ANAB and K stock pages for the full models.
Not investment advice.